Mimo AG
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2018–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Mimo ranks #48,764 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.
- #48,764
- of 49,997 US assignees by volume
- 10th percentile
- by Innovation Score (22.3/100)
- 13.6
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R48764 · Foreign Corporation #48,764 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,764/49,997
- PHOTO-FINISH Mikasa Sangyo
- CPC-NARROW A61B · 5 areas
- INNOV-THIN 22.3/100
- CLAIMS-RICH 13.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Mikasa Sangyo Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Mimo’s 22.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Mimo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Mimo · this assignee 22
Mimo · this assignee
22 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Mimo's Innovation Score is 22.3/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Mimo?
Each dot is one of Mimo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mimo’s own 13.6 claims/patent is ABOVE the 12.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Mimo's grants concentrate
Mimo AG is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (3 grants) versus a trough of 2 in 2019. By volume, Mimo sits between Mikasa Sangyo Co., Ltd. and Minima Technology Co., Ltd..
Who files at Mimo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Mikasa Sangyo
Mikasa Sangyo Co., Ltd.
5 patents
- Mikron Agno
Mikron SA Agno
5 patents
- Milabs B V
Milabs B.V.
5 patents
- Milton ROY
Milton ROY, LLC
5 patents
- Mimsi Materials AB
Mimsi Materials AB
5 patents
- Mindhive
Mindhive Inc.
5 patents
- Mingsight Pharmac…
Mingsight Pharmaceuticals, Inc.
5 patents
- Minima Technology
Minima Technology Co., Ltd.
5 patents
- Mimo ◀
Mimo AG
5 patents
What this shows Mimo holds 5 patents at rank #48,641, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Mimo
By rank, the assignees closest to #48,641 in granted patent volume.
- Mikasa Sangyo Co., Ltd. #48,637 · 5 patents
- Mikron SA Agno #48,638 · 5 patents
- Milabs B.V. #48,639 · 5 patents
- Milton ROY, LLC #48,640 · 5 patents
- Mimsi Materials AB #48,642 · 5 patents
- Mindhive Inc. #48,643 · 5 patents
- Mingsight Pharmaceuticals, Inc. #48,644 · 5 patents
- Minima Technology Co., Ltd. #48,645 · 5 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Mimo's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Mimo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
22 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 3 | 60.0% |
| 2019 | 2 | 40.0% |
Which technologies does Mimo AG patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Mimo AG's patent record in context - here's where to go next.
- Mimo AG's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 80% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #48,764 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Mimo AG against Mikasa Sangyo Co., Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.